Related Experiment Video
Updated: Jul 4, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Gene therapy for gastric diseases
Shintaro Fumoto1, Junya Nishi, Junzo Nakamura
1Graduate School of Biomedical Sciences, Nagasaki University, Japan.
Abstract:
Gene therapy for gastric cancer and gastric ulcer is a rationalized strategy since various genes correlate with these diseases. Since gene expressions in non-target tissues/cells cause side effects, a selective gene delivery system targeted to the stomach and/or cancer must be developed. The route of vector transfer (direct injection, systemic, intraperitoneal, gastric serosal surface and oral administration) is an important issue which can determine efficacy and safety. Strategies for cancer gene therapy can be categorized as suicide gene therapy, growth inhibition and apoptosis induction, immunotherapy, anti-angiogenesis, and others. Combination of the target gene with other genes and/or strategies such as chemotherapy and virotherapy is promising. Candidates for treatment of gastric ulcer are vascular endothelial growth factor, angiopoietin-1, serum response factor, and cationic host defense peptide cathelicidin. In this review, we discuss stomach- and cancer-targeted gene transfer methods and summarize gene therapy trials for gastric cancer and gastric ulcer.
Insights
Gene therapy offers a promising approach for gastric cancer and ulcers by targeting specific genes. Developing selective delivery systems is crucial for effective and safe stomach-specific treatments.
Area of Science:
- Oncology
- Gastroenterology
- Molecular Biology
Background:
- Gene therapy is a viable strategy for gastric cancer and ulcers due to gene-disease correlations.
- Non-target gene expression can lead to adverse effects, necessitating targeted delivery systems.
Purpose of the Study:
- To review stomach- and cancer-targeted gene transfer methods.
- To summarize current gene therapy trials for gastric cancer and gastric ulcer.
Main Methods:
- Discussion of various vector transfer routes (e.g., direct injection, oral administration).
- Categorization of gastric cancer gene therapy strategies (e.g., suicide gene therapy, immunotherapy).
- Identification of potential therapeutic genes for gastric ulcer (e.g., VEGF, angiopoietin-1).
Main Results:
- Selective gene delivery to the stomach and cancer cells is essential for efficacy and safety.
- Combination therapies (gene + chemotherapy/virotherapy) show promise.
- Specific genes like VEGF and cathelicidin are candidates for gastric ulcer treatment.
Conclusions:
- Targeted gene therapy holds significant potential for treating gastric cancer and ulcers.
- Further development of targeted delivery systems and combination strategies is warranted.
Related Concept Videos
Gene Therapy
Gene Therapy
Gastritis II: Pathophysiology
What is Monogastric Digestion?
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
